Briefing Information for the November 2, 2011 Meeting of the Oncologic Drugs Advisory Committee
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
FDA Briefing Information for the November 2, 2011 Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PDF – 61KB)